Sperax
Rendimiento
Conversor
Métricas
Liquidez
Clasificación
En Cryp2Nova
Eventos recientes
Actividad social
Enlaces
Contratos
0x5575…40ad4bPrincipales mercados
Oferta
Últimas noticias
Datos clave
Sperax en cifras
Sperax (SPA) ocupa el puesto #1230 por capitalización de mercado, con $5.53M. Pertenece al sector Stablecoins (Algorithmic Stablecoin). Cotiza desde el 10 de abril de 2022 en 39 mercados de 10 exchanges, con un volumen de $262.34K en las últimas 24 horas. Su máximo histórico de $0.169545 se alcanzó el 6 de mayo de 2022; el precio actual está un 98.7% por debajo. Su mínimo del ciclo, $0.00185145, llegó el 31 de julio de 2026.
Circula el 38.3% del suministro máximo de 5.00B SPA. Cuenta con 7 inversores registrados, entre ellos Outlier Ventures, Alameda Research, Amber Group. En Arbitrum, 263,544 direcciones tienen SPA. Está disponible en 3 redes.
Acerca de Sperax
Sperax focuses on building DeFi products with access across L1 and L2 blockchains. With the Sperax token (SPA) at its core, Sperax has built an auto-Yield stablecoin, USDs.
Antecedentes
Launched in 2020, Sperax is headquartered in NYC. After envisioning a Sperax Layer 1 blockchain, the team transitioned to building the first auto-yield bearing stablecoin: Sperax USD (USDs).
In December 2021, Sperax released USDs on L2 Arbitrum. Residing on-chain, USDs is backed by collateral and algorithmically by the protocol’s ability to mint $1 worth of SPA when redeeming $1 of USDs. USDs combines the scalability benefits of algorithmic stablecoins with the stability benefits of collateralized stablecoins.
USDs holders benefit from native auto-yield, meaning that holders automatically earn yield without having to stake or claim. The yield is generated organically from the collateral deployed on external DeFi protocols like Curve Finance.
Sperax’s roadmap is to construct a full-stack DeFi ecosystem based on USDs. As the USDs ecosystem expands through organic and partnership growth, the team plans to vitalize the L1 conceived during the company’s incipient stage.
Sperax is backed by Polychain Capital, Jump Trading, Alameda Research, Amber Group, and DJ Steve Aoki.

